Home > Papers

 
 
The distribution of human papillomavirus genotypes in uterine cervical lesions in Yanbian of Northern China
Zhao Yiwei 1,Lin Hai 2,Wu Qunying 1,Han Songying 1,Zhang Meihua 1,Lin Zhenhua 3 * #
1.Department of Pathology, Yanbian University College of Medicine
2.Division of Nephrology, Department of Medicine, University of Maryland School of Medicine
3.Department of Pathology, Yanbian University College of Medicine;2.Key Laboratory of Natural Resources of the Changbai Mountain and Functional Molecules (Yanbian University);3.Department of Pathology, Johns Hopkins University Medical Institutions, USA
*Correspondence author
#Submitted by
Subject:
Funding: Program of New Century Talents in University,National Natural Science Foundation of China,The Excellent Youth Scientific Study Fund of Jilin Province,(No.2007,30560047,20050115,2005-383)
Opened online: 9 October 2007
Accepted by: none
Citation: Zhao Yiwei ,Lin Hai ,Wu Qunying .The distribution of human papillomavirus genotypes in uterine cervical lesions in Yanbian of Northern China[OL]. [ 9 October 2007] http://en.paper.edu.cn/en_releasepaper/content/15558
 
 
Purposes: To investigate the distribution of human papillomavirus (HPV) genotypes in uterine cervical lesions in Yanbian of Northern China. Materials and Methods: Paraffin embedded blocks of 62 cases of squamous cell carcinomas (SCC), 28 cases of adenocarcinomas, and 143 cases of CIN (CIN-1: 45; CIN-2: 46; CIN-3: 52) were selected from Dept. of Pathology, Yanbian University Hospital and Yanbian Women’s Hospital in the period of 2000-2005. DNA was extracted by using High Pure PCR Template Preparation Kit from all above blocks. And HPV genotypes were detected by using oligonucleotide microarray (HPV DNA-chip). Results: All the 20 cases of normal cervical epithelia are negative for HPV by both TaKaRa PCR and DNA-chip methods. The positive rate of high-risk HPV is 28.9% in CIN-1, 41.3% in CIN-2, 44.2% in CIN-3, 85.5% in SCC, and 82.1% in adenocarcinoma by TaKaRa PCR method. Similarly, it is 26.7% in CIN-1, 41.3% in CIN-2, 40.4% in CIN-3, 82.3% in SCC, and 78.6% in adenocarcinoma by HPV DNA-chip. HPV 16 is the major type in all CIN and SCC cervical lesions. However, in cervical adenocarcinoma, HPV 18 is the most common type (59.1% in HPV positive cases), and HPV 16 is the second type, but still show a high percentage (31.8% in HPV positive cases). There is small number of multi-types HPV detected in CIN-3, SCC, and adenocarcinoma, but none in CIN-1/2. Meanwhile, there is no significant difference on the HPV screening between TaKaRa PCR and HPV DNA-chip methods (p<0.05). Conclusions: HPV 16 is the type most frequently involved in the development of SCC of the cervix, whereas both HPV 18 and 16 play a prominent role in the development of adenocarcinoma of the cervix in Yanbian of Northern China. Both TaKaRa PCR and HPV DNA-chip methods are sensitive for HPV detection, and can be used for the screening of HPV infection status and genotyping in uterine cervical lesions, and maybe helpful for the prediction of the development and progress of CIN-2/3.
Keywords:Papillomavirus, Human; Uterine Cervix; Genotyping
 
 
 

For this paper

  • PDF (0B)
  • ● Revision 0   
  • ● Print this paper
  • ● Recommend this paper to a friend
  • ● Add to my favorite list

    Saved Papers

    Please enter a name for this paper to be shown in your personalized Saved Papers list

Tags

Add yours

Related Papers

Statistics

PDF Downloaded 472
Bookmarked 0
Recommend 5
Comments Array
Submit your papers